Earnings estimate | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
---|---|---|---|---|
No. of analysts | 0 | 0 | 0 | 0 |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low estimate | 0 | 0 | 0 | 0 |
High estimate | 0 | 0 | 0 | 0 |
Year ago EPS | N/A | N/A | N/A | N/A |
Revenue estimate | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
---|---|---|---|---|
No. of analysts | 0 | 0 | 4 | 4 |
Avg. Estimate | N/A | N/A | 14.49B | 16.65B |
Low estimate | N/A | N/A | 13.92B | 15.83B |
High estimate | N/A | N/A | 15.3B | 18.3B |
Year ago sales | N/A | N/A | 12.44B | 14.49B |
Sales growth (year/est) | N/A | N/A | 16.50% | 14.90% |
Earnings history | Invalid Date | Invalid Date | 30/06/2017 | 30/09/2018 |
---|---|---|---|---|
Est. EPS | N/A | N/A | 9.35 | 11.67 |
Actual EPS | N/A | N/A | 4.77 | 7.65 |
Difference | N/A | N/A | -4.58 | -4.02 |
Surprise % | N/A | N/A | -49.00% | -34.40% |
EPS trend | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
---|---|---|---|---|
Current estimate | 0 | 0 | 0 | 0 |
7 days ago | 0 | 0 | 38.66 | 49.14 |
30 days ago | 0 | 0 | 38.66 | 49.14 |
60 days ago | 0 | 0 | 38.66 | 49.14 |
90 days ago | 0 | 0 | 38.66 | 49.14 |
EPS revisions | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2019) | Next year (2020) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | AARTIDRUGS.BO | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | N/A | N/A | N/A | N/A |
Next qtr. | N/A | N/A | N/A | N/A |
Current year | N/A | N/A | N/A | N/A |
Next year | N/A | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |